KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Moderna (MRNA) Shares Repurchased (2021 - 2023)

Historic Shares Repurchased for Moderna (MRNA) over the last 3 years, with Q3 2023 value amounting to -$1.0 million.

  • Moderna's Shares Repurchased fell 10009.94% to -$1.0 million in Q3 2023 from the same period last year, while for Jun 2024 it was -$1.0 million, marking a year-over-year decrease of 10003.9%. This contributed to the annual value of $1.2 billion for FY2023, which is 6536.5% down from last year.
  • Per Moderna's latest filing, its Shares Repurchased stood at -$1.0 million for Q3 2023, which was down 10009.94% from $628.0 million recorded in Q2 2023.
  • Moderna's 5-year Shares Repurchased high stood at $1.3 billion for Q2 2022, and its period low was -$1.0 million during Q3 2023.
  • For the 3-year period, Moderna's Shares Repurchased averaged around $667.4 million, with its median value being $625.5 million (2022).
  • Data for Moderna's Shares Repurchased shows a peak YoY increase of 1556.98% (in 2023) and a maximum YoY decrease of 10009.94% (in 2023) over the last 5 years.
  • Quarter analysis of 3 years shows Moderna's Shares Repurchased stood at $857.0 million in 2021, then crashed by 53.09% to $402.0 million in 2022, then crashed by 100.25% to -$1.0 million in 2023.
  • Its Shares Repurchased stands at -$1.0 million for Q3 2023, versus $628.0 million for Q2 2023 and $526.0 million for Q1 2023.